Damora Therapeutics, Inc.
Status: Publicly traded
Last reviewed: October 2026
Direct answer
Damora Therapeutics, Inc. is publicly traded on NASDAQ under the ticker DMRA.
Damora Therapeutics, Inc., a biopharmaceutical company, develops therapies for the treatment of hematologic disorders in Denmark and North America. The company’s lead product includes DMR-001, a investigational monoclonal antibody therapy that targets mutations in CALR, for the treatment of essential thrombocythemia; and DMR-002 and DMR-003, both anti-mutCALR-based therapies, with the intent to ultimately address...
Can you invest in Damora Therapeutics, Inc.?
Yes. Damora Therapeutics, Inc. trades publicly on NASDAQ as DMRA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Damora Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.